{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "a65dc9b8",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "import spacy\n",
    "from spacy import displacy\n",
    "import spacy\n",
    "from spacy.tokens import DocBin\n",
    "from tqdm import tqdm\n",
    "import pandas as pd\n",
    "import json\n",
    "from spacy.util import filter_spans #to idenify overlapping entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "faaf7640",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['tok2vec', 'tagger', 'parser', 'attribute_ruler', 'lemmatizer', 'ner']\n"
     ]
    }
   ],
   "source": [
    "nlp = spacy.load(\"en_core_web_lg\")\n",
    "doc = nlp(\"hello i am dev\")\n",
    " \n",
    "print(nlp.pipe_names)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "67dd8186",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">hello i am \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dev\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "displacy.render(doc, style=\"ent\", jupyter=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "317e6d31",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Antiretroviral therapy ( ART ) is recommended for all HIV-infected individuals</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "string = \"Antiretroviral therapy ( ART ) is recommended for all HIV-infected individuals\"\n",
    "doc = nlp(string)\n",
    "displacy.render(doc, style=\"ent\", jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "7eb932ca",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = pd.read_csv('../../datasets/ncbi-disease/traindata.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "4f655e55",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>entities</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Identification of APC2  a homologue of the  ad...</td>\n",
       "      <td>{\"entities\": [[1131, 1137, \"SpecificDisease\"],...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>A common MSH2 mutation in English and North Am...</td>\n",
       "      <td>{\"entities\": [[135, 152, \"SpecificDisease\"], [...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Age of onset in  Huntington disease    sex spe...</td>\n",
       "      <td>{\"entities\": [[169, 171, \"SpecificDisease\"], [...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Familial deficiency of the seventh component o...</td>\n",
       "      <td>{\"entities\": [[0, 58, \"SpecificDisease\"], [146...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Increased incidence of  cancer  in patients wi...</td>\n",
       "      <td>{\"entities\": [[1023, 1043, \"SpecificDisease\"],...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>788</th>\n",
       "      <td>atm and p53 cooperate in apoptosis and suppres...</td>\n",
       "      <td>{\"entities\": [[524, 540, \"SpecificDisease\"], [...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>789</th>\n",
       "      <td>Trinucleotide repeat expansion at the  myotoni...</td>\n",
       "      <td>{\"entities\": [[95, 113, \"SpecificDisease\"], [8...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>790</th>\n",
       "      <td>Constitutively methylated CpG dinucleotides as...</td>\n",
       "      <td>{\"entities\": [[74, 88, \"Modifier\"], [211, 225,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>791</th>\n",
       "      <td>The  von Hippel Lindau tumor  suppressor gene ...</td>\n",
       "      <td>{\"entities\": [[236, 267, \"SpecificDisease\"], [...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>792</th>\n",
       "      <td>Adult onset globoid cell leukodystrophy    Kra...</td>\n",
       "      <td>{\"entities\": [[273, 276, \"SpecificDisease\"], [...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>793 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  text  \\\n",
       "0    Identification of APC2  a homologue of the  ad...   \n",
       "1    A common MSH2 mutation in English and North Am...   \n",
       "2    Age of onset in  Huntington disease    sex spe...   \n",
       "3    Familial deficiency of the seventh component o...   \n",
       "4    Increased incidence of  cancer  in patients wi...   \n",
       "..                                                 ...   \n",
       "788  atm and p53 cooperate in apoptosis and suppres...   \n",
       "789  Trinucleotide repeat expansion at the  myotoni...   \n",
       "790  Constitutively methylated CpG dinucleotides as...   \n",
       "791  The  von Hippel Lindau tumor  suppressor gene ...   \n",
       "792  Adult onset globoid cell leukodystrophy    Kra...   \n",
       "\n",
       "                                              entities  \n",
       "0    {\"entities\": [[1131, 1137, \"SpecificDisease\"],...  \n",
       "1    {\"entities\": [[135, 152, \"SpecificDisease\"], [...  \n",
       "2    {\"entities\": [[169, 171, \"SpecificDisease\"], [...  \n",
       "3    {\"entities\": [[0, 58, \"SpecificDisease\"], [146...  \n",
       "4    {\"entities\": [[1023, 1043, \"SpecificDisease\"],...  \n",
       "..                                                 ...  \n",
       "788  {\"entities\": [[524, 540, \"SpecificDisease\"], [...  \n",
       "789  {\"entities\": [[95, 113, \"SpecificDisease\"], [8...  \n",
       "790  {\"entities\": [[74, 88, \"Modifier\"], [211, 225,...  \n",
       "791  {\"entities\": [[236, 267, \"SpecificDisease\"], [...  \n",
       "792  {\"entities\": [[273, 276, \"SpecificDisease\"], [...  \n",
       "\n",
       "[793 rows x 2 columns]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "753d0e07",
   "metadata": {},
   "outputs": [],
   "source": [
    "#data format = [(text,entities)]\n",
    "\n",
    "train_data  = [] \n",
    "\n",
    "for i in range(len(data)):\n",
    "    dic = json.loads(data.iloc[i].entities)\n",
    "    toTup = [tuple(lst) for lst in dic['entities']]\n",
    "    tup = {'text' : data.iloc[i].text ,'entities' : toTup }\n",
    "    train_data.append(tup)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "a7ab5d1a",
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp = spacy.blank(\"en\") # load a new spacy model\n",
    "doc_bin = DocBin() # create a DocBin object"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "d072f7a6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 21%|████████████████████████████▎                                                                                                        | 169/793 [00:00<00:01, 581.99it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 53%|██████████████████████████████████████████████████████████████████████▉                                                              | 423/793 [00:00<00:00, 786.30it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 87%|███████████████████████████████████████████████████████████████████████████████████████████████████████████████████▋                 | 690/793 [00:00<00:00, 829.69it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████| 793/793 [00:01<00:00, 766.49it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n",
      "Skipping entity\n"
     ]
    }
   ],
   "source": [
    "for training_example  in tqdm(train_data): \n",
    "    text = training_example['text']\n",
    "    labels = training_example['entities']\n",
    "    doc = nlp.make_doc(text) \n",
    "    ents = []\n",
    "    for start, end, label in labels:\n",
    "        span = doc.char_span(start, end, label=label, alignment_mode=\"contract\")\n",
    "        if span is None:\n",
    "            print(\"Skipping entity\")\n",
    "        else:\n",
    "            ents.append(span)\n",
    "    filtered_ents = filter_spans(ents)\n",
    "    doc.ents = filtered_ents \n",
    "    doc_bin.add(doc)\n",
    "\n",
    "doc_bin.to_disk(\"../../datasets/training_data.spacy\") # save the docbin object"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "6fa39f42",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2023-03-27 22:52:09.747095: I tensorflow/core/platform/cpu_feature_guard.cc:193] This TensorFlow binary is optimized with oneAPI Deep Neural Network Library (oneDNN) to use the following CPU instructions in performance-critical operations:  AVX2 AVX512F AVX512_VNNI FMA\n",
      "To enable them in other operations, rebuild TensorFlow with the appropriate compiler flags.\n",
      "2023-03-27 22:52:09.839801: I tensorflow/core/util/port.cc:104] oneDNN custom operations are on. You may see slightly different numerical results due to floating-point round-off errors from different computation orders. To turn them off, set the environment variable `TF_ENABLE_ONEDNN_OPTS=0`.\n",
      "2023-03-27 22:52:09.842247: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libcudart.so.11.0'; dlerror: libcudart.so.11.0: cannot open shared object file: No such file or directory\n",
      "2023-03-27 22:52:09.842261: I tensorflow/compiler/xla/stream_executor/cuda/cudart_stub.cc:29] Ignore above cudart dlerror if you do not have a GPU set up on your machine.\n",
      "2023-03-27 22:52:10.233654: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libnvinfer.so.7'; dlerror: libnvinfer.so.7: cannot open shared object file: No such file or directory\n",
      "2023-03-27 22:52:10.233699: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libnvinfer_plugin.so.7'; dlerror: libnvinfer_plugin.so.7: cannot open shared object file: No such file or directory\n",
      "2023-03-27 22:52:10.233704: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Cannot dlopen some TensorRT libraries. If you would like to use Nvidia GPU with TensorRT, please make sure the missing libraries mentioned above are installed properly.\n",
      "2023-03-27 22:52:10.798465: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libcuda.so.1'; dlerror: libcuda.so.1: cannot open shared object file: No such file or directory\n",
      "2023-03-27 22:52:10.798486: W tensorflow/compiler/xla/stream_executor/cuda/cuda_driver.cc:265] failed call to cuInit: UNKNOWN ERROR (303)\n",
      "2023-03-27 22:52:10.798498: I tensorflow/compiler/xla/stream_executor/cuda/cuda_diagnostics.cc:156] kernel driver does not appear to be running on this host (devang): /proc/driver/nvidia/version does not exist\n",
      "\u001b[38;5;2m✔ Auto-filled config with all values\u001b[0m\n",
      "\u001b[38;5;2m✔ Saved config\u001b[0m\n",
      "config.cfg\n",
      "You can now add your data and train your pipeline:\n",
      "python -m spacy train config.cfg --paths.train ./train.spacy --paths.dev ./dev.spacy\n"
     ]
    }
   ],
   "source": [
    "!python -m spacy init fill-config base_config.cfg config.cfg\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "29959ce2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2023-03-26 18:39:50.275252: I tensorflow/core/platform/cpu_feature_guard.cc:193] This TensorFlow binary is optimized with oneAPI Deep Neural Network Library (oneDNN) to use the following CPU instructions in performance-critical operations:  AVX2 AVX512F AVX512_VNNI FMA\n",
      "To enable them in other operations, rebuild TensorFlow with the appropriate compiler flags.\n",
      "2023-03-26 18:39:50.368964: I tensorflow/core/util/port.cc:104] oneDNN custom operations are on. You may see slightly different numerical results due to floating-point round-off errors from different computation orders. To turn them off, set the environment variable `TF_ENABLE_ONEDNN_OPTS=0`.\n",
      "2023-03-26 18:39:50.371411: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libcudart.so.11.0'; dlerror: libcudart.so.11.0: cannot open shared object file: No such file or directory\n",
      "2023-03-26 18:39:50.371426: I tensorflow/compiler/xla/stream_executor/cuda/cudart_stub.cc:29] Ignore above cudart dlerror if you do not have a GPU set up on your machine.\n",
      "2023-03-26 18:39:50.770362: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libnvinfer.so.7'; dlerror: libnvinfer.so.7: cannot open shared object file: No such file or directory\n",
      "2023-03-26 18:39:50.770409: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libnvinfer_plugin.so.7'; dlerror: libnvinfer_plugin.so.7: cannot open shared object file: No such file or directory\n",
      "2023-03-26 18:39:50.770416: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Cannot dlopen some TensorRT libraries. If you would like to use Nvidia GPU with TensorRT, please make sure the missing libraries mentioned above are installed properly.\n",
      "2023-03-26 18:39:51.398560: W tensorflow/compiler/xla/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libcuda.so.1'; dlerror: libcuda.so.1: cannot open shared object file: No such file or directory\n",
      "2023-03-26 18:39:51.398586: W tensorflow/compiler/xla/stream_executor/cuda/cuda_driver.cc:265] failed call to cuInit: UNKNOWN ERROR (303)\n",
      "2023-03-26 18:39:51.398600: I tensorflow/compiler/xla/stream_executor/cuda/cuda_diagnostics.cc:156] kernel driver does not appear to be running on this host (devang): /proc/driver/nvidia/version does not exist\n",
      "\u001b[38;5;4mℹ Saving to output directory: .\u001b[0m\n",
      "\u001b[38;5;4mℹ Using CPU\u001b[0m\n",
      "\u001b[1m\n",
      "=========================== Initializing pipeline ===========================\u001b[0m\n",
      "[2023-03-26 18:39:51,777] [INFO] Set up nlp object from config\n",
      "[2023-03-26 18:39:51,784] [INFO] Pipeline: ['tok2vec', 'ner']\n",
      "[2023-03-26 18:39:51,786] [INFO] Created vocabulary\n",
      "[2023-03-26 18:39:51,786] [INFO] Finished initializing nlp object\n",
      "[2023-03-26 18:39:53,786] [INFO] Initialized pipeline components: ['tok2vec', 'ner']\n",
      "\u001b[38;5;2m✔ Initialized pipeline\u001b[0m\n",
      "\u001b[1m\n",
      "============================= Training pipeline =============================\u001b[0m\n",
      "\u001b[38;5;4mℹ Pipeline: ['tok2vec', 'ner']\u001b[0m\n",
      "\u001b[38;5;4mℹ Initial learn rate: 0.001\u001b[0m\n",
      "E    #       LOSS TOK2VEC  LOSS NER  ENTS_F  ENTS_P  ENTS_R  SCORE \n",
      "---  ------  ------------  --------  ------  ------  ------  ------\n",
      "  0       0          0.00    134.94    1.27    2.32    0.87    0.01\n",
      "  0     200       1892.82   4587.45   65.63   70.16   61.64    0.66\n",
      "  0     400       3551.58   2288.21   65.61   65.17   66.05    0.66\n",
      "  1     600       4099.24   1620.53   72.34   73.06   71.64    0.72\n",
      "  1     800        303.85   1276.07   80.29   81.52   79.09    0.80\n",
      "  1    1000       1369.38   1215.20   78.08   77.77   78.39    0.78\n",
      "  2    1200        402.25    981.22   79.51   80.38   78.65    0.80\n",
      "  2    1400       1240.27    956.17   81.97   82.38   81.56    0.82\n",
      "  2    1600       1772.57   1020.35   83.97   84.82   83.14    0.84\n",
      "  3    1800        615.72    873.83   84.16   83.81   84.51    0.84\n",
      "  3    2000        633.96    750.45   85.24   85.22   85.27    0.85\n",
      "  3    2200        559.58    728.93   84.64   84.95   84.34    0.85\n",
      "  4    2400        631.08    774.34   86.81   86.76   86.85    0.87\n",
      "  4    2600       1100.86    810.35   86.82   86.24   87.42    0.87\n",
      "  4    2800        841.17    759.43   88.49   88.66   88.31    0.88\n",
      "  5    3000       2319.28    676.11   89.87   89.68   90.06    0.90\n",
      "  5    3200        869.65    516.22   87.37   87.70   87.04    0.87\n",
      "  5    3400       1263.01    641.90   90.63   90.90   90.36    0.91\n",
      "  6    3600       1241.15    664.36   89.93   90.00   89.85    0.90\n",
      "  6    3800       3888.13    756.95   90.80   90.72   90.88    0.91\n",
      "  7    4000       1873.43    829.72   89.51   89.52   89.49    0.90\n",
      "  7    4200       5827.60   1269.31   92.18   92.28   92.07    0.92\n",
      "  8    4400       1762.26   1108.47   92.78   92.79   92.76    0.93\n",
      " 10    4600       3330.07   1418.54   93.78   93.68   93.88    0.94\n",
      " 11    4800       2607.69   1346.69   94.22   94.27   94.16    0.94\n",
      " 12    5000       2531.66   1246.91   93.55   93.57   93.52    0.94\n",
      " 13    5200       1416.52    961.69   93.41   93.41   93.42    0.93\n",
      " 15    5400       2143.70   1001.59   95.38   95.43   95.32    0.95\n",
      " 16    5600       2873.71    965.99   95.18   95.17   95.19    0.95\n",
      " 17    5800       3068.69    866.81   95.67   95.65   95.69    0.96\n",
      " 18    6000       2919.73    767.85   96.56   96.51   96.62    0.97\n",
      " 20    6200       6086.66    791.93   96.72   96.68   96.77    0.97\n",
      " 21    6400       2949.89    671.40   97.15   97.11   97.19    0.97\n",
      " 22    6600       2647.98    567.31   97.37   97.38   97.36    0.97\n",
      " 23    6800       3390.88    658.44   97.19   97.15   97.22    0.97\n",
      " 25    7000       3815.58    681.25   97.59   97.64   97.55    0.98\n",
      " 26    7200       2376.82    542.66   97.62   97.62   97.62    0.98\n",
      " 27    7400       3212.47    551.37   97.37   97.38   97.36    0.97\n",
      " 29    7600       3365.08    531.23   97.31   97.32   97.30    0.97\n",
      " 30    7800       3404.87    508.65   97.63   97.61   97.66    0.98\n",
      " 31    8000      11786.11    572.44   98.06   98.06   98.06    0.98\n",
      " 32    8200       6334.70    593.88   97.75   97.76   97.74    0.98\n",
      " 34    8400       2666.15    379.70   97.86   97.87   97.85    0.98\n",
      " 35    8600       4168.51    445.49   98.17   98.17   98.16    0.98\n",
      " 36    8800       5475.26    497.35   98.25   98.23   98.27    0.98\n",
      " 37    9000       3545.29    376.72   98.57   98.54   98.61    0.99\n",
      " 39    9200       4255.31    367.93   98.56   98.54   98.57    0.99\n",
      " 40    9400       7328.82    433.29   97.70   97.72   97.68    0.98\n",
      " 41    9600       5613.14    385.53   98.61   98.61   98.61    0.99\n",
      " 43    9800       3902.82    380.78   99.05   99.07   99.03    0.99\n",
      " 44   10000      10386.66    346.13   98.88   98.90   98.86    0.99\n",
      " 45   10200       3542.72    304.59   99.00   98.99   99.01    0.99\n",
      " 46   10400       5924.28    353.70   98.89   98.93   98.84    0.99\n",
      " 48   10600       2811.39    279.77   99.04   99.03   99.05    0.99\n",
      " 49   10800       4069.02    276.30   99.20   99.20   99.20    0.99\n",
      " 50   11000       7027.47    315.10   99.09   99.05   99.13    0.99\n",
      " 51   11200      40204.21    429.83   99.08   99.09   99.07    0.99\n",
      " 53   11400      51046.31    340.30   99.33   99.28   99.37    0.99\n",
      " 54   11600      10798.68    286.00   99.13   99.16   99.11    0.99\n",
      " 55   11800       5180.57    218.89   98.96   98.97   98.95    0.99\n",
      " 56   12000       6278.24    242.58   99.41   99.41   99.41    0.99\n",
      " 58   12200      10187.90    243.70   99.23   99.24   99.22    0.99\n",
      " 59   12400       7559.49    229.28   99.32   99.30   99.33    0.99\n",
      " 60   12600      13620.67    238.35   99.40   99.43   99.37    0.99\n",
      " 61   12800       4216.67    185.28   99.57   99.58   99.56    1.00\n",
      " 63   13000       5709.98    240.52   99.49   99.51   99.47    0.99\n",
      " 64   13200       3439.50    174.34   99.36   99.34   99.39    0.99\n",
      " 65   13400       3027.77    177.25   99.20   99.20   99.20    0.99\n",
      " 67   13600       4849.96    148.26   99.47   99.47   99.47    0.99\n",
      " 68   13800       5074.98    175.44   99.50   99.49   99.51    0.99\n",
      " 69   14000       6958.32    175.93   99.61   99.62   99.60    1.00\n",
      " 70   14200       4479.15    158.74   99.52   99.52   99.52    1.00\n",
      " 72   14400       3294.90    113.17   99.70   99.70   99.70    1.00\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " 73   14600       2135.31     77.36   99.77   99.75   99.79    1.00\n",
      " 74   14800       2145.45     91.30   99.72   99.73   99.71    1.00\n",
      " 75   15000       4206.21    115.52   99.59   99.58   99.60    1.00\n",
      " 77   15200       3179.87    114.35   99.73   99.73   99.73    1.00\n",
      " 78   15400       3467.65     98.32   99.85   99.85   99.85    1.00\n",
      " 79   15600       5118.43    148.95   99.50   99.49   99.51    0.99\n",
      " 81   15800       2522.41     97.96   99.72   99.71   99.73    1.00\n",
      " 82   16000       6103.51    132.21   99.74   99.75   99.73    1.00\n",
      " 83   16200       3448.12     94.74   99.36   99.37   99.35    0.99\n",
      " 84   16400       5622.80    150.68   99.44   99.45   99.43    0.99\n",
      " 86   16600      13027.95    173.04   99.81   99.81   99.81    1.00\n",
      " 87   16800       6417.98     86.63   99.87   99.87   99.87    1.00\n",
      " 88   17000       4873.78     80.57   99.87   99.87   99.87    1.00\n",
      " 89   17200       6665.25    130.86   99.49   99.49   99.49    0.99\n",
      " 91   17400       9229.86    166.18   99.78   99.77   99.79    1.00\n",
      " 92   17600      10015.75    172.54   99.60   99.66   99.54    1.00\n",
      " 93   17800       4386.66    110.66   99.90   99.90   99.90    1.00\n",
      " 94   18000       4624.52     86.69   99.83   99.81   99.85    1.00\n",
      " 96   18200      12159.50    124.43   99.71   99.71   99.71    1.00\n",
      " 97   18400       8156.18     87.35   99.87   99.85   99.89    1.00\n",
      " 98   18600       9638.83    105.61   99.65   99.64   99.66    1.00\n",
      "100   18800       6962.00    116.63   99.80   99.81   99.79    1.00\n",
      "101   19000      13245.02    170.40   99.73   99.77   99.70    1.00\n",
      "102   19200       4064.22     69.93   99.72   99.71   99.73    1.00\n",
      "103   19400      11977.25    147.90   99.62   99.60   99.64    1.00\n",
      "\u001b[38;5;2m✔ Saved pipeline to output directory\u001b[0m\n",
      "model-last\n"
     ]
    }
   ],
   "source": [
    "!python -m spacy train config.cfg --output ./ --paths.train ./training_data.spacy --paths.dev ./training_data.spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "8b412e72",
   "metadata": {},
   "outputs": [],
   "source": [
    "def findEntity(text):\n",
    "    nlp_ner = spacy.load(\"model-best\")\n",
    "\n",
    "    doc = nlp_ner(text)\n",
    "\n",
    "    colors = {\"SpecificDisease\": \"#F67DE3\", \"DiseaseClass\": \"#7DF6D9\", \"CompositeMention\":\"#FF3355\",\"Modifier\":\"#68FF33\"}\n",
    "    options = {\"colors\": colors} \n",
    "\n",
    "    spacy.displacy.render(doc, style=\"ent\", options= options, jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "dcab9f63",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Identification of APC2  a homologue of the  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenomatous polyposis coli tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  suppressor   The  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenomatous polyposis coli   APC   tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  suppressor protein controls the Wnt signalling pathway by forming a complex with glycogen synthase kinase 3beta   GSK 3beta     axin   conductin and betacatenin   Complex formation induces the rapid degradation of betacatenin   In  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colon carcinoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  cells   loss of APC leads to the accumulation of betacatenin in the nucleus   where it binds to and activates the Tcf 4 transcription factor   reviewed in   1     2       Here   we report the identification and genomic structure of APC homologues   Mammalian APC2   which closely resembles APC in overall domain structure   was functionally analyzed and shown to contain two SAMP domains   both of which are required for binding to conductin   Like APC   APC2 regulates the formation of active betacatenin Tcf complexes   as demonstrated using transient transcriptional activation assays in APC        \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colon carcinoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  cells   Human APC2 maps to chromosome 19p13   3   APC and APC2 may therefore have comparable functions in development and  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">A common MSH2 mutation in English and North American  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HNPCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  families  origin  phenotypic expression  and sex specific differences in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    The frequency   origin   and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hereditary non polyposis cancer syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HNPCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "   was investigated   The mutation   A     T at nt943   3   disrupts the 3 splice site of exon 5 leading to the deletion of this exon from MSH2 mRNA and represents the only frequent MSH2 mutation so far reported   Although this mutation was initially detected in four of 33  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  families analysed from eastern England   more extensive analysis has reduced the frequency to four of 52   8     English  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HNPCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  kindreds analysed   In contrast   the MSH2 mutation was identified in 10 of 20   50     separately identified  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  families from Newfoundland   To investigate the origin of this mutation in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  families from England   n   4     Newfoundland   n   10     and the United States   n   3     haplotype analysis using microsatellite markers linked to MSH2 was performed   Within the English and US families there was little evidence for a recent common origin of the MSH2 splice site mutation in most families   In contrast   a common haplotype was identified at the two flanking markers   CA5 and D2S288   in eight of the Newfoundland families   These findings suggested a founder effect within Newfoundland similar to that reported by others for two MLH1 mutations in Finnish  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HNPCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  families   We calculated age related risks of all    \n",
       "<mark class=\"entity\" style=\"background: #FFFFFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal   endometrial   and ovarian cancers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CompositeMention</span>\n",
       "</mark>\n",
       "  in nt943   3 A     T MSH2 mutation carriers   n   76   for all patients and for men and women separately   For both sexes combined   the penetrances at age 60 years for all  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "   and for  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  were 0   86 and 0   57   respectively   The risk of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  was significantly higher   p   0   01   in males than females   0   63 v 0   30 and 0   84 v 0   44 at ages 50 and 60 years   respectively     For females there was a high risk of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endometrial cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    0   5 at age 60 years   and  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    premenopausal ovarian cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    0   2 at 50 years     These intersex differences in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  risks have implications for screening programmes and for attempts to identify  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  susceptibility modifiers</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Age of onset in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Huntington disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    sex specific influence of apolipoprotein E genotype and normal CAG repeat length   Age of onset   AO   of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Huntington disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "   is known to be correlated with the length of an expanded CAG repeat in the  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  gene   Apolipoprotein E   APOE   genotype   in turn   is known to influence AO in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alzheimer disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    rendering the APOE gene a likely candidate to affect AO in other  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neurological diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  too   We therefore determined APOE genotype and normal CAG repeat length in the  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  gene for 138  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  patients who were previously analysed with respect to CAG repeat length   Genotyping for APOE was performed blind to clinical information   In addition to highlighting the effect of the normal repeat length upon AO in maternally inherited  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and in male patients   we show that the APOE epsilon2epsilon3 genotype is associated with significantly earlier AO in males than in females   Such a sex difference in AO was not apparent for any of the other APOE genotypes   Our findings suggest that subtle differences in the course of the  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neurodegeneration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "   in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "   may allow interacting genes to exert gender specific effects upon AO</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">\n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Familial deficiency of the seventh component of complement\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  associated with recurrent  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bacteremic infections due to Neisseria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "    The serum of a 29 year old woman with a recent episode of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    disseminated gonococcal infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and a history of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    meningococcal meningitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arthritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  as a child was found to lack serum hemolytic complement activity   The seventh component of complement   C7   was not detected by functional or immunochemical assays   whereas other components were normal by hemolytic and immunochemical assessment   Her fresh serum lacked complement mediated bactericidal activity against Neisseria gonorrhoeae   but the addition of fresh normal serum or purified C7 restored bactericidal activity as well as hemolytic activity   The  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    absence of functional C7\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  activity could not be accounted for on the basis of an inhibitor   Opsonization and generation of chemotactic activity functioned normally    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Complete absence of C7\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  was also found in one sibling who had the clinical syndrome of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    meningococcal meningitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arthritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "   as a child and in this siblings clinically well eight year old son   HLA histocompatibility typing of the family members did not demonstrate evidence for genetic linkage of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    C7 deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  with the major histocompatibility loci   This report represents the first cases of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    C7 deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  associated with infectious complications and suggests that bactericidal activity may be important in host defense against  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bacteremic neisseria infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Increased incidence of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  in patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cartilage hair hypoplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    OBJECTIVE  Previous reports have suggested an increased risk of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  among patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cartilage hair hypoplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     This study was carried out to further evaluate this risk among patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and their first degree relatives   STUDY DESIGN  One hundred twenty two patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  were identified through 2 countrywide epidemiologic surveys in   and in     Their parents and nonaffected siblings were identified through the Population Register Center   This cohort underwent follow up for  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  incidence through the Finnish Cancer Registry to the end of     RESULTS  A statistically significant excess risk of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  was seen among the patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    standardized incidence ratio 6   9   95   confidence interval 2   3 to 16     which was mainly attributable to  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non Hodgkins lymphoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     standardized incidence ratio 90   95   confidence interval 18 to 264     In addition   a significant excess risk of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    basal cell carcinoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  was seen   standardized incidence ratio 35   95   confidence interval 7   2 to 102     The  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  incidence among the siblings or the parents did not differ from the average  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  incidence in the Finnish population   CONCLUSIONS  This study confirms an increased risk of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "   especially  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non Hodgkins lymphoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    probably attributable to defective immunity   among patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Genotype and phenotype in patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dihydropyrimidine dehydrogenase deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dihydropyrimidine dehydrogenase   DPD   deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  is an  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autosomal recessive disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  characterised by thymine uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype   In order to understand the genetic and phenotypic basis for  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DPD deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    we have reviewed 17 families presenting 22 patients with complete  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deficiency of DPD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    In this group of patients   7 different mutations have been identified   including 2 deletions   295 298delTCAT    delC     1 splice site mutation   IVS14   1G   A     and 4 missense mutations   85T   C   703C   T    G   A    G   T     Analysis of the prevalence of the various mutations among  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DPD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  patients has shown that the G     A point mutation in the invariant splice donor site is by far the most common   52       whereas the other six mutations are less frequently observed   A large phenotypic variability has been observed   with  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    convulsive disorders\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    motor retardation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  and  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mental retardation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  being the most abundant manifestations   A clear correlation between the genotype and phenotype has not been established   An altered beta alanine   uracil and thymine homeostasis might underlie the various  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clinical abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  encountered in patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DPD deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Fibroblast growth factor homologous factor 2  FHF2   gene structure  expression and mapping to the  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Borjeson Forssman Lehmann syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  region in Xq26 delineated by a duplication breakpoint in a  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BFLS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  like patient    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Borjeson Forssman Lehmann syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BFLS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    is a syndromal  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    X linked mental retardation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "    which maps by linkage to the q26 region of the human X chromosome   We have identified a male patient with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BFLS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  like features and a duplication   46   Y   dup   X     q26q28     inherited from his phenotypically normal mother   Fluorescence in situ hybridisation using yeast artificial chromosome clones from Xq26 localised the duplication breakpoint to an approximately 400 kb interval in the Xq26   3 region between DXS155 and DXS294   DXS730   Database searches and analysis of available genomic DNA sequence from the region revealed the presence of the fibroblast growth factor homologous factor gene   FHF2   within the duplication breakpoint interval   The gene structure of FHF2 was determined and two new exons were identified   including a new 5 end exon   1B   FHF2 is a large gene extending over approximately 200 kb in Xq26   3 and is composed of at least seven exons   It shows tissue specific alternative splicing and alternative transcription starts   Northern blot hybridisation showed highest expression in brain and skeletal muscle   The FHF2 gene localisation and tissue specific expression pattern suggest it to be a candidate gene for familial cases of the  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BFLS syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and other syndromal and non specific forms of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    X linked mental retardation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  mapping to the region</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Germline E cadherin gene  CDH1  mutations predispose to  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    familial gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    Inherited mutations in the E cadherin gene   CDH1   were described recently in three Maori kindreds with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    familial gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Familial gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  is genetically heterogeneous and it is not clear what proportion of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  susceptibility in non Maori populations is due to germline CDH1 mutations   Therefore   we screened eight  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    familial gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  kindreds of British and Irish origin for germline CDH1 mutations   by SSCP analysis of all 16 exons and flanking sequences   Each family contained    i   two cases of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  in first degree relatives with one affected before age 50 years   or   ii   three or more cases of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    Novel germline CDH1 mutations   a nonsense and a splice site   were detected in two families   25       Both mutations were predicted to truncate the E cadherin protein in the signal peptide domain   In one family there was evidence of non penetrance and susceptibility to both  \n",
       "<mark class=\"entity\" style=\"background: #FFFFFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric and colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CompositeMention</span>\n",
       "</mark>\n",
       "    thus   in addition to six cases of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    a CDH1 mutation carrier developed  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  at age 30 years   We have confirmed that germline mutations in the CDH1 gene cause  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    familial gastric cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  in non Maori populations   However   only a minority of familial  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric cancers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  can be accounted for by CDH1 mutations   Loss of E cadherin function has been implicated in the pathogenesis of sporadic  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal and other cancers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "    and our findings provide evidence that germline CDH1 mutations predispose to early onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    Thus   CDH1 should be investigated as a cause of inherited susceptibility to both  \n",
       "<mark class=\"entity\" style=\"background: #FFFFFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric and colorectal cancers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CompositeMention</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">A zinc finger truncation of murine WT1 results in the characteristic  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    urogenital abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Denys Drash syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     The  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wilms tumor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "   suppressor gene   WT1   plays a key role in urogenital development   and  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WT1 dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  is implicated in both  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neoplastic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wilms tumor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mesothelioma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    leukemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    and  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    and  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nonneoplastic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glomerulosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    disease   The analysis of diseases linked specifically with WT1 mutations   such as  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Denys Drash syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DDS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "      can provide valuable insight concerning the role of WT1 in development and disease    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DDS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  is a rare childhood disease characterized by a  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  involving  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mesangial sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    XY  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pseudohermaphroditism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    and   or  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wilms tumor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "       \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DDS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  patients are constitutionally heterozygous for exonic point mutations in WT1   which include mutations predicted to truncate the protein within the C terminal zinc finger   ZF   region   We report that heterozygosity for a targeted murine Wt1 allele   Wt1   tmT396     which truncates ZF3 at codon 396   induces  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mesangial sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  characteristic of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DDS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  in adult heterozygous and chimeric mice    \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Male genital defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  also were evident and there was a single case of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wilms tumor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  in which the transcript of the nontargeted allele showed an exon 9 skipping event   implying a causal link between  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wt1 dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wilms tumorigenesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  in mice   However   the mutant WT1   tmT396   protein accounted for only 5   of WT1 in both heterozygous embryonic stem cells and the  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    This has implications regarding the mechanism by which the mutant allele exerts its effect</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Mechanism of increased iron absorption in murine model of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hereditary hemochromatosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    increased duodenal expression of the iron transporter DMT1    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hereditary hemochromatosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    is a common  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autosomal recessive disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  characterized by tissue iron deposition secondary to excessive dietary iron absorption   We recently reported that HFE   the protein defective in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    was physically associated with the transferrin receptor   TfR   in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin bound iron from plasma by duodenal crypt cells   leading to up regulation of transporters for dietary iron   Here   we tested the hypothesis that HFE      mice have increased duodenal expression of the divalent metal transporter   DMT1     By 4 weeks of age   the HFE      mice demonstrated iron loading when compared with HFE       littermates   with elevated transferrin saturations   68   4   vs   49   8     and elevated liver iron concentrations   985 micrograms vs   381 micrograms     By using Northern blot analyses   we quantitated duodenal expression of both classes of DMT1 transcripts  one containing an iron responsive element   IRE     called DMT1   IRE     and one containing no IRE   called DMT1   non IRE     The positive control for DMT1 up regulation was a murine model of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dietary iron deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  that demonstrated greatly increased levels of duodenal DMT1   IRE   mRNA   HFE      mice also demonstrated an increase in duodenal DMT1   IRE   mRNA   average 7   7 fold     despite their elevated transferrin saturation and hepatic iron content   Duodenal expression of DMT1   non IRE   was not increased   nor was hepatic expression of DMT1 increased   These data support the model for \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       " in which HFE mutations lead to inappropriately low crypt cell iron   with resultant stabilization of DMT1   IRE   mRNA   up regulation of DMT1   and increased absorption of dietary iron</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Neurophysiologic follow up of long term dietary treatment in adult onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenoleukodystrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    OBJECTIVE  To monitor the effects of dietary treatment in adult onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenoleukodystrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    by means of somatosensory evoked potentials   SEPs   and motor evoked potentials   MEPs     BACKGROUND  SEPs and MEPs have proved useful in revealing signs of progressively severe   central  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dying back axonopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  in early stages of adult onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    METHODS  Eight patients with adult onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  underwent clinical examination   brain and spine MRI   and SEP and MEP studies before and after 3 years of Lorenzos oil dietary therapy   RESULTS  Before treatment   brain MRI was normal in five patients   Three of these patients had pure  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spinal SEP abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  and in the remaining two patients SEPs showed signs of involvement of both the spinal and cerebral somatosensory tracts   After treatment   the three patients with pure  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spinal abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  showed clinical and neurophysiologic worsening   whereas the two patients with a more advanced stage of disease   exhibited by SEPs   showed substantially unchanged clinical and neurophysiologic features   The patients with abnormal brain MRI at the onset of treatment showed clinical and neurophysiologic worsening   CONCLUSIONS  Lorenzos oil therapy had no effect on patients with evidence of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammatory brain lesions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "    Moreover   in patients without clear signs of inflammatory damage   this treatment does not modify significantly the natural course of the disease   However   because effective treatments should begin before the onset of severe neurologic symptoms   SEPs and MEPs should be considered to evaluate the effectiveness of other experimental treatments in the patient with a negative brain MRI</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">GCH1 mutation in a patient with adult onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oromandibular dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    The authors report a mutation in exon 5 of GCH1 in a patient with adult onset  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oromandibular dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and no obvious family history of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "    The patient responded positively to treatment with L dopa   These findings demonstrate that GCH1 mutations must be considered even in patients with  \n",
       "<mark class=\"entity\" style=\"background: ##5DADE2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dystonic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  symptoms not typical of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dopa responsive dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "i = 0\n",
    "for i in range(len(data)):\n",
    "    findEntity(data.iloc[i].text)\n",
    "    if i > 10:\n",
    "        break\n",
    "    i+=1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "21fd8360",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\"></div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nlp_ner = spacy.load(\"model-best\")\n",
    "\n",
    "doc = nlp_ner(\"\")\n",
    "\n",
    "colors = {\"SpecificDisease\": \"#F67DE3\", \"DiseaseClass\": \"#7DF6D9\", \"CompositeMention\":\"#FFFFFF\",\"Modifier\":\"#ffff05\"}\n",
    "options = {\"colors\": colors} \n",
    "\n",
    "spacy.displacy.render(doc, style=\"ent\", options= options, jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "b147e526",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body  \n",
       "<mark class=\"entity\" style=\"background: #FF3355; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cancer can occur in any part of the body and can spread to other parts through the blood and lymphatic systems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CompositeMention</span>\n",
       "</mark>\n",
       "  There are many different types of cancer  each with its own characteristics  symptoms  and treatment options   Here are some of the most common types of cancer   \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Breast Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Breast cancer is the most common cancer in women worldwide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  It occurs when abnormal cells in the breast tissue begin to grow and divide uncontrollably  Symptoms include a lump or thickening in the breast or underarm  nipple discharge or tenderness  and changes in the size or shape of the breast   \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lung Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  Lung cancer is the leading cause of cancer death worldwide  It occurs when abnormal cells in the lungs grow and divide uncontrollably  Symptoms include coughing  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  shortness of breath  and wheezing   \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Prostate Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  Prostate cancer is the most common cancer in men after skin cancer  It occurs when abnormal cells in the prostate gland begin to grow and divide uncontrollably  Symptoms include difficulty urinating  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weak urine flow\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  blood in the urine  and erectile dysfunction   \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Colorectal Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Colorectal cancer is the third most common cancer worldwide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  It occurs when abnormal cells in the colon or rectum grow and divide uncontrollably  Symptoms include abdominal pain  constipation  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and rectal bleeding   \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Skin Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  Skin cancer is the most common type of cancer in the United States  It occurs when abnormal cells in the skin grow and divide uncontrollably  Symptoms include changes in the color  size  or shape of a mole or other skin lesion  as well as sores that do not heal   Leukemia  Leukemia is a type of blood cancer that affects the bone marrow and blood cells  It occurs when abnormal white blood cells grow and divide uncontrollably  Symptoms include fatigue  \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  and easy bleeding or bruising   Lymphoma  Lymphoma is a type of blood cancer that affects the lymphatic system  It occurs when abnormal lymphocytes  a type of white blood cell  grow and divide uncontrollably  Symptoms include swollen lymph nodes  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  weight loss  and night sweats   There are many other types of cancer as well  each with its own unique characteristics  symptoms  and treatment options  Early detection and treatment are key to improving outcomes for people with cancer</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "text = '''Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer can occur in any part of the body and can spread to other parts through the blood and lymphatic systems. There are many different types of cancer, each with its own characteristics, symptoms, and treatment options.\n",
    "\n",
    "Here are some of the most common types of cancer:\n",
    "\n",
    "Breast Cancer: Breast cancer is the most common cancer in women worldwide. It occurs when abnormal cells in the breast tissue begin to grow and divide uncontrollably. Symptoms include a lump or thickening in the breast or underarm, nipple discharge or tenderness, and changes in the size or shape of the breast.\n",
    "\n",
    "Lung Cancer: Lung cancer is the leading cause of cancer death worldwide. It occurs when abnormal cells in the lungs grow and divide uncontrollably. Symptoms include coughing, chest pain, shortness of breath, and wheezing.\n",
    "\n",
    "Prostate Cancer: Prostate cancer is the most common cancer in men after skin cancer. It occurs when abnormal cells in the prostate gland begin to grow and divide uncontrollably. Symptoms include difficulty urinating, weak urine flow, blood in the urine, and erectile dysfunction.\n",
    "\n",
    "Colorectal Cancer: Colorectal cancer is the third most common cancer worldwide. It occurs when abnormal cells in the colon or rectum grow and divide uncontrollably. Symptoms include abdominal pain, constipation, diarrhea, and rectal bleeding.\n",
    "\n",
    "Skin Cancer: Skin cancer is the most common type of cancer in the United States. It occurs when abnormal cells in the skin grow and divide uncontrollably. Symptoms include changes in the color, size, or shape of a mole or other skin lesion, as well as sores that do not heal.\n",
    "\n",
    "Leukemia: Leukemia is a type of blood cancer that affects the bone marrow and blood cells. It occurs when abnormal white blood cells grow and divide uncontrollably. Symptoms include fatigue, weakness, infections, and easy bleeding or bruising.\n",
    "\n",
    "Lymphoma: Lymphoma is a type of blood cancer that affects the lymphatic system. It occurs when abnormal lymphocytes (a type of white blood cell) grow and divide uncontrollably. Symptoms include swollen lymph nodes, fever, weight loss, and night sweats.\n",
    "\n",
    "There are many other types of cancer as well, each with its own unique characteristics, symptoms, and treatment options. Early detection and treatment are key to improving outcomes for people with cancer.\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "'''\n",
    "text = cleanText(text)\n",
    "findEntity(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "468e02d6",
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "def cleanText(text):\n",
    "    text = re.sub(r'<category=\\\"(\\w+)\\\">',' ',text)\n",
    "    text = re.sub(r'</category>',' ',text)\n",
    "    text = re.sub(r'[0-9]{4,}',' ',text)\n",
    "    text = re.sub(r'\\t',' ',text)\n",
    "    text = re.sub(r'[^a-zA-Z0-9]',' ',text)\n",
    "#     text = re.sub(r'[ ]{2,}',' ',text)\n",
    "    text=text.strip()\n",
    "    return text\n",
    "#currently not eliminating numbers, we can replace it with \"num\" will do it later"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "447c0310",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Severe diseases are medical conditions that are characterized by significant and often life threatening symptoms and complications  These diseases can impact various parts of the body and can have a wide range of causes  including genetic factors  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  environmental exposures  and lifestyle factors   Here are some examples of severe diseases   \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body  It can occur in any part of the body and can spread to other parts through the blood and lymphatic systems  Depending on the type and stage of cancer  it can be a very serious and potentially life threatening disease   \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  Heart disease refers to a range of conditions that impact the heart  including coronary artery disease  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and arrhythmias  These conditions can cause chest pain  shortness of breath  and other symptoms  and can lead to serious complications such as heart attack and stroke   Chronic obstructive pulmonary disease  COPD   COPD is a chronic lung disease that makes it difficult to breathe  It includes conditions such as emphysema and \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic bronchitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and is often caused by smoking or exposure to other environmental factors  COPD can lead to severe breathing difficulties  and is a leading cause of disability and death worldwide   Diabetes  Diabetes is a condition in which the body is unable to properly regulate blood sugar levels  It can cause a range of symptoms  including fatigue  increased thirst and urination  and blurred vision  If left untreated  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes can lead to serious complications such as heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and nerve damage   Alzheimer s disease  Alzheimer s disease is a type of dementia that affects memory  thinking  and behavior  It is characterized by the buildup of abnormal proteins in the brain  and is the most common cause of dementia in older adults  Alzheimer s disease is a progressive condition that can eventually lead to severe memory loss and loss of independence   HIV AIDS  HIV AIDS is a viral infection that attacks the immune system  It is spread through sexual contact  sharing needles  or from mother to child during pregnancy  childbirth  or breastfeeding  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HIV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       " AIDS can lead to a range of symptoms and complications  and is a leading cause of death worldwide   Stroke  A stroke occurs when blood flow to the brain is disrupted  leading to damage to brain cells  It can cause a range of symptoms  including weakness or numbness on one side of the body  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    difficulty speaking or understanding speech\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and vision problems  Stroke can be life threatening  and can cause long term disability or death   These are just a few examples of severe diseases  Many other conditions can also be considered severe  and it is important to seek medical attention if you experience any symptoms that are concerning or unusual  Early detection and treatment can help improve outcomes and quality of life for people living with severe diseases</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "text = '''Severe diseases are medical conditions that are characterized by significant and often life-threatening symptoms and complications. These diseases can impact various parts of the body and can have a wide range of causes, including genetic factors, infections, environmental exposures, and lifestyle factors.\n",
    "\n",
    "Here are some examples of severe diseases:\n",
    "\n",
    "Cancer: Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. It can occur in any part of the body and can spread to other parts through the blood and lymphatic systems. Depending on the type and stage of cancer, it can be a very serious and potentially life-threatening disease.\n",
    "\n",
    "Heart disease: Heart disease refers to a range of conditions that impact the heart, including coronary artery disease, heart failure, and arrhythmias. These conditions can cause chest pain, shortness of breath, and other symptoms, and can lead to serious complications such as heart attack and stroke.\n",
    "\n",
    "Chronic obstructive pulmonary disease (COPD): COPD is a chronic lung disease that makes it difficult to breathe. It includes conditions such as emphysema and chronic bronchitis, and is often caused by smoking or exposure to other environmental factors. COPD can lead to severe breathing difficulties, and is a leading cause of disability and death worldwide.\n",
    "\n",
    "Diabetes: Diabetes is a condition in which the body is unable to properly regulate blood sugar levels. It can cause a range of symptoms, including fatigue, increased thirst and urination, and blurred vision. If left untreated, diabetes can lead to serious complications such as heart disease, kidney failure, and nerve damage.\n",
    "\n",
    "Alzheimer's disease: Alzheimer's disease is a type of dementia that affects memory, thinking, and behavior. It is characterized by the buildup of abnormal proteins in the brain, and is the most common cause of dementia in older adults. Alzheimer's disease is a progressive condition that can eventually lead to severe memory loss and loss of independence.\n",
    "\n",
    "HIV/AIDS: HIV/AIDS is a viral infection that attacks the immune system. It is spread through sexual contact, sharing needles, or from mother to child during pregnancy, childbirth, or breastfeeding. HIV/AIDS can lead to a range of symptoms and complications, and is a leading cause of death worldwide.\n",
    "\n",
    "Stroke: A stroke occurs when blood flow to the brain is disrupted, leading to damage to brain cells. It can cause a range of symptoms, including weakness or numbness on one side of the body, difficulty speaking or understanding speech, and vision problems. Stroke can be life-threatening, and can cause long-term disability or death.\n",
    "\n",
    "These are just a few examples of severe diseases. Many other conditions can also be considered severe, and it is important to seek medical attention if you experience any symptoms that are concerning or unusual. Early detection and treatment can help improve outcomes and quality of life for people living with severe diseases.\n",
    "\n",
    "'''\n",
    "text = cleanText(text)\n",
    "findEntity(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "id": "73a2dd76",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">corruption is a cancer for any country</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "text = ''' corruption is a cancer for any country\n",
    "'''\n",
    "text = cleanText(text)\n",
    "findEntity(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "a74e48f7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Cancer is a complex and heterogeneous disease that arises from a combination of genetic and environmental factors  Despite significant progress in cancer research  it remains one of the leading causes of morbidity and mortality worldwide  Understanding the underlying mechanisms of cancer development and progression is critical for the development of effective therapies and personalized treatment strategies   Recent advances in genomics  transcriptomics  proteomics  and metabolomics have enabled researchers to gain a better understanding of the molecular pathways that drive cancer growth and metastasis  The use of high throughput sequencing technologies and computational approaches has facilitated the identification of cancer driver genes and the characterization of somatic mutations that contribute to tumor progression   In addition to genetic mutations  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    the tumor microenvironment has emerged as a critical factor in cancer progression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  The interaction between cancer cells and the surrounding stroma  including immune cells  fibroblasts  and blood vessels  plays a critical role in cancer growth and metastasis  Targeting the tumor microenvironment has shown promise as a therapeutic strategy in various cancers  including \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    melanoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lung cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and pancreatic cancer   Immunotherapy has also emerged as a promising treatment strategy in cancer  The use of checkpoint inhibitors  which target proteins that prevent T cell activation  has shown remarkable efficacy in various cancers  including \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    melanoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  non small cell lung cancer  and renal cell carcinoma  However  the response to immunotherapy varies among patients  and identifying biomarkers that predict response remains an active area of research   Precision medicine  which involves tailoring treatment based on the individual patient s genomic profile  has shown promise in various cancers  including \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lung cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    melanoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  The use of next generation sequencing technologies has enabled the identification of actionable mutations that can guide treatment decisions  However  challenges remain in implementing precision medicine in routine clinical practice  including the cost of sequencing and the need for robust evidence to support the clinical utility of genomic testing   In conclusion  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       " research has made significant progress in recent years  with advances in genomics  immunotherapy  and precision medicine  However  challenges remain in developing effective therapies and implementing precision medicine in routine clinical practice  Continued investment in cancer research is critical to improving outcomes for cancer patients and reducing the burden of this devastating disease</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "text = '''Cancer is a complex and heterogeneous disease that arises from a combination of genetic and environmental factors. Despite significant progress in cancer research, it remains one of the leading causes of morbidity and mortality worldwide. Understanding the underlying mechanisms of cancer development and progression is critical for the development of effective therapies and personalized treatment strategies.\n",
    "\n",
    "Recent advances in genomics, transcriptomics, proteomics, and metabolomics have enabled researchers to gain a better understanding of the molecular pathways that drive cancer growth and metastasis. The use of high-throughput sequencing technologies and computational approaches has facilitated the identification of cancer driver genes and the characterization of somatic mutations that contribute to tumor progression.\n",
    "\n",
    "In addition to genetic mutations, the tumor microenvironment has emerged as a critical factor in cancer progression. The interaction between cancer cells and the surrounding stroma, including immune cells, fibroblasts, and blood vessels, plays a critical role in cancer growth and metastasis. Targeting the tumor microenvironment has shown promise as a therapeutic strategy in various cancers, including melanoma, lung cancer, and pancreatic cancer.\n",
    "\n",
    "Immunotherapy has also emerged as a promising treatment strategy in cancer. The use of checkpoint inhibitors, which target proteins that prevent T-cell activation, has shown remarkable efficacy in various cancers, including melanoma, non-small cell lung cancer, and renal cell carcinoma. However, the response to immunotherapy varies among patients, and identifying biomarkers that predict response remains an active area of research.\n",
    "\n",
    "Precision medicine, which involves tailoring treatment based on the individual patient's genomic profile, has shown promise in various cancers, including breast cancer, lung cancer, and melanoma. The use of next-generation sequencing technologies has enabled the identification of actionable mutations that can guide treatment decisions. However, challenges remain in implementing precision medicine in routine clinical practice, including the cost of sequencing and the need for robust evidence to support the clinical utility of genomic testing.\n",
    "\n",
    "In conclusion, cancer research has made significant progress in recent years, with advances in genomics, immunotherapy, and precision medicine. However, challenges remain in developing effective therapies and implementing precision medicine in routine clinical practice. Continued investment in cancer research is critical to improving outcomes for cancer patients and reducing the burden of this devastating disease.\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "'''\n",
    "text = cleanText(text)\n",
    "findEntity(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "5b9ee2b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Clustering of missense mutations in the  \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ataxia telangiectasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  gene in a  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sporadic T cell leukaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ataxia telangiectasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A T\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    is a  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    recessive multi system disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  caused by mutations in the ATM gene at 11q22 q23   ref   3     The risk of  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "    especially  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lymphoid neoplasias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    is substantially elevated in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A T\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  patients and has long been associated with chromosomal instability   By analysing  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  DNA from patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sporadic T cell prolymphocytic leukaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T PLL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "      a rare  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clonal malignancy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  with similarities to a  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mature T cell leukaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  seen in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A T\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    we demonstrate a high frequency of ATM mutations in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T PLL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    In marked contrast to the ATM mutation pattern in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A T\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    the most frequent nucleotide changes in this  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    leukaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  were missense mutations   These clustered in the region corresponding to the kinase domain   which is highly conserved in ATM related proteins in mouse   yeast and Drosophila   The resulting amino acid substitutions are predicted to interfere with ATP binding or substrate recognition   Two of seventeen mutated  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T PLL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  samples had a previously reported  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A T\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  allele   In contrast   no mutations were detected in the p53 gene   suggesting that this  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  suppressor is not frequently altered in this  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    leukaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    Occasional missense mutations in ATM were also found in  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  DNA from patients with  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B cell non Hodgkins lymphomas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "     \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B NHL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "    and a  \n",
       "<mark class=\"entity\" style=\"background: #68FF33; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B NHL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Modifier</span>\n",
       "</mark>\n",
       "  cell line   The evidence of a significant proportion of loss of function mutations and a complete absence of the normal copy of ATM in the majority of mutated  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  establishes somatic inactivation of this gene in the pathogenesis of  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sporadic T PLL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  and suggests that ATM acts as a  \n",
       "<mark class=\"entity\" style=\"background: #7DF6D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DiseaseClass</span>\n",
       "</mark>\n",
       "  suppressor   As constitutional DNA was not available   a putative hereditary predisposition to  \n",
       "<mark class=\"entity\" style=\"background: #F67DE3; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T PLL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">SpecificDisease</span>\n",
       "</mark>\n",
       "  will require further investigation</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "text = '''\n",
    "9288106\tClustering of missense mutations in the <category=\"Modifier\">ataxia-telangiectasia</category> gene in a <category=\"SpecificDisease\">sporadic T-cell leukaemia</category>.\t<category=\"SpecificDisease\">Ataxia-telangiectasia</category> ( <category=\"SpecificDisease\">A-T</category> ) is a <category=\"DiseaseClass\">recessive multi-system disorder</category> caused by mutations in the ATM gene at 11q22-q23 ( ref . 3 ) . The risk of <category=\"DiseaseClass\">cancer</category> , especially <category=\"DiseaseClass\">lymphoid neoplasias</category> , is substantially elevated in <category=\"Modifier\">A-T</category> patients and has long been associated with chromosomal instability . By analysing <category=\"Modifier\">tumour</category> DNA from patients with <category=\"SpecificDisease\">sporadic T-cell prolymphocytic leukaemia</category> ( <category=\"SpecificDisease\">T-PLL</category> ) , a rare <category=\"DiseaseClass\">clonal malignancy</category> with similarities to a <category=\"SpecificDisease\">mature T-cell leukaemia</category> seen in <category=\"SpecificDisease\">A-T</category> , we demonstrate a high frequency of ATM mutations in <category=\"SpecificDisease\">T-PLL</category> . In marked contrast to the ATM mutation pattern in <category=\"SpecificDisease\">A-T</category> , the most frequent nucleotide changes in this <category=\"DiseaseClass\">leukaemia</category> were missense mutations . These clustered in the region corresponding to the kinase domain , which is highly conserved in ATM-related proteins in mouse , yeast and Drosophila . The resulting amino-acid substitutions are predicted to interfere with ATP binding or substrate recognition . Two of seventeen mutated <category=\"SpecificDisease\">T-PLL</category> samples had a previously reported <category=\"Modifier\">A-T</category> allele . In contrast , no mutations were detected in the p53 gene , suggesting that this <category=\"Modifier\">tumour</category> suppressor is not frequently altered in this <category=\"DiseaseClass\">leukaemia</category> . Occasional missense mutations in ATM were also found in <category=\"Modifier\">tumour</category> DNA from patients with <category=\"SpecificDisease\">B-cell non-Hodgkins lymphomas</category> ( <category=\"SpecificDisease\">B-NHL</category> ) and a <category=\"Modifier\">B-NHL</category> cell line . The evidence of a significant proportion of loss-of-function mutations and a complete absence of the normal copy of ATM in the majority of mutated <category=\"DiseaseClass\">tumours</category> establishes somatic inactivation of this gene in the pathogenesis of <category=\"SpecificDisease\">sporadic T-PLL</category> and suggests that ATM acts as a <category=\"Modifier\">tumour</category> suppressor . As constitutional DNA was not available , a putative hereditary predisposition to <category=\"SpecificDisease\">T-PLL</category> will require further investigation . . \n",
    "'''\n",
    "text = cleanText(text)\n",
    "findEntity(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c41a232a",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
